Literature DB >> 16989919

In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate).

Hong Sung Kim1, In Ho Song, Jong Chul Kim, Eun Jeong Kim, Doo Ok Jang, Yong Serk Park.   

Abstract

We chemically synthesized two different cationic lipids consisting of a core of lysine, two C-14 hydrocarbon chains, and either aspartatic acid or glutamic acid. The lipids were assigned the acronyms, DMKD and DMKE. Cationic liposomes prepared with the two different lipids were tested for their gene-transferring capabilities in various cell lines compared with that of control DOTAP liposomes. Under the same experimental conditions, the order of in vitro gene transfection efficiency was DMKE>or=DMKD>DOTAP. To identify the parameters influencing transfection efficiency, the DNA-binding affinities of the liposomes were compared and changes in particle size and surface charge were examined after complex formation. Both the DNA-binding affinity of the liposomes and the cell surface-binding affinity of the liposome-pDNA complexes were crucial for gene transfection. In addition, intravenously administered DMKE and DMKD liposomes exhibited different biodistribution characteristics and intensity of in vivo organ transfection from the DOTAP liposomes. Compared to the DOTAP liposomes, they were more readily transferred to the liver. Interestingly, when they were directly injected into tumor tissues, the DMKE lipoplexes were able to induce more efficient transgene expression in these tissues than the DOTAP and DMKD lipoplexes. This study suggests that a small difference in the cationic lipid backbone structure significantly affects gene-transferring capabilities. DMKE and DMKD liposomes can be utilized as efficient gene-transferring vehicles for hepatic or intra-tumoral gene transfection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16989919     DOI: 10.1016/j.jconrel.2006.08.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

1.  Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs.

Authors:  Y K Lee; T S Lee; I H Song; H Y Jeong; S J Kang; M W Kim; S H Ryu; I H Jung; J S Kim; Y S Park
Journal:  Cancer Gene Ther       Date:  2015-04-10       Impact factor: 5.987

2.  cRGD grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment.

Authors:  Nirav Khatri; Mohan Rathi; Dipesh Baradia; Ambikanandan Misra
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

3.  Herbal ethosomal gel containing luliconazole for productive relevance in the field of biomedicine.

Authors:  Vivek Dave; Nishant Bhardwaj; Nikita Gupta; Kajal Tak
Journal:  3 Biotech       Date:  2020-02-06       Impact factor: 2.406

4.  Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles.

Authors:  Min Woo Kim; Hwa Yeon Jeong; Seong Jae Kang; Moon Jung Choi; Young Myoung You; Chan Su Im; Tae Sup Lee; In Ho Song; Chang Gun Lee; Ki-Jong Rhee; Yeon Kyung Lee; Yong Serk Park
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

5.  A DNA dual lock-and-key strategy for cell-subtype-specific siRNA delivery.

Authors:  Kewei Ren; Ying Liu; Jie Wu; Yue Zhang; Jing Zhu; Min Yang; Huangxian Ju
Journal:  Nat Commun       Date:  2016-11-24       Impact factor: 14.919

6.  A multifunctional DNA nano-scorpion for highly efficient targeted delivery of mRNA therapeutics.

Authors:  Dandan Li; Fei Mo; Jiangling Wu; Yong Huang; Huihao Zhou; Shijia Ding; Weixian Chen
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

7.  Innovative approaches for cancer treatment: current perspectives and new challenges.

Authors:  Carlotta Pucci; Chiara Martinelli; Gianni Ciofani
Journal:  Ecancermedicalscience       Date:  2019

8.  Sendai F/HN viroplexes for efficient transfection of leukemic T cells.

Authors:  Jung Seok Kim; Yeon Kyung Lee; Hwa Yeon Jeong; Seong Jae Kang; Min Woo Kim; Seung Hyun Ryu; Hong Sung Kim; Keun Sik Kim; Dong-Eun Kim; Yong Serk Park
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.